Clinical Trials Directory

Trials / Completed

CompletedNCT06262165

Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis

BILAN: Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood BIomarker ANaLysis

Status
Completed
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
15 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The main goal of the BIocoLlection in Anorexia Nervosa-liver damage evaluation BILAN study the blood biomarkers associated with liver cytolysis.

Detailed description

Study of the association between blood biomarkers and the presence of hepatic cytolysis, defined by AST and/or ALT above normal.

Conditions

Interventions

TypeNameDescription
OTHERPatients with Anorexia NervosaPatients with Anorexia Nervosa hospitalized for malnutrition

Timeline

Start date
2024-02-16
Primary completion
2025-06-27
Completion
2025-06-27
First posted
2024-02-15
Last updated
2026-04-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06262165. Inclusion in this directory is not an endorsement.